GlassScriptPhysician profile
Tracy L Young
NPI 1093700114
$745.40
in general payments reported to CMS, 2019-2025
13 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.46 · 2022: $231 · 2023: $96.92 · 2024: $134 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $457.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $161.48 | 2022-2025 | Precision 1, Precision7, Total30 |
| Sun Pharmaceutical Industries INC. | $137.16 | 2021-2025 | Cequa |
| Oyster Point Pharma, INC. | $81.60 | 2022 | |
| Coopervision INC. | $61.64 | 2024-2025 | Clariti Contact Lens, Myday Contact Lens |
| Regeneron Healthcare Solutions, INC. | $57.40 | 2024-2025 | Eylea |
| Bausch & Lomb Americas INC. | $55.20 | 2022-2025 | Infuse, Miebo |
| Allergan, INC. | $38.10 | 2022 | |
| Novartis Pharmaceuticals Corporation | $34.70 | 2022-2023 | |
| Rayner Intraocular Lenses Limited | $28.80 | 2023 | Rayone Aspheric, Omidria, Rayone Emv |
| Sight Sciences, INC. | $24.16 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $23.72 | 2025 | Xdemvy |
| Genentech USA, INC. | $22.47 | 2025 | Vabysmo |
| Abbvie INC. | $18.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.